Increased Gal-7 expression in cervical cancer is often associated with heightened sensitivity to concurrent chemoradiotherapy (CCRT), although Gal-7 alone is not an independent predictor of CCRT sensitivity. Here, LGALS7 is linked to cervical cancer.